Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lessons learnt, and still to learn, in first in human stem cell trials

22 Dec 2022

Abstract excerpt

Developing cellular therapies is not straightforward. This Perspective summarizes the experience of a group of academic stem cell investigators working in different clinical areas and aims to share insight into what we wished we knew before starting. These include (1) choosing the stem cell line and assessing the genome of both the starting and final product, (2) familiarity with GMP manufacturing, reagent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to Cancer Genomics and Diagnostics
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36563687
DOI: 10.1016/j.stemcr.2022.11.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lessons learnt, and still to learn, in first in human stem cell trialsPMID 36563687Read ↗

The King is Dead, Long Live the King: Entering A New Era of Stem Cell Research and Clinical DevelopmentSemantic proximity Read ↗

ISSCR’s Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventionsSemantic proximity Read ↗

Clinical development of gene- and cell-based therapies: overview of the European landscapeSemantic proximity Read ↗

Developing Standards to Support the Clinical Translation of Stem CellsSemantic proximity Read ↗

Geron trial resumes, but standards for stem cell trials remain elusiveSemantic proximity Read ↗

Considerations for manufacturing of cell and gene medicines for clinical developmentSemantic proximity Read ↗

The Procurement of Cells for the Derivation of Human Embryonic Stem Cell Lines for Therapeutic Use: Recommendations for Good PracticeSemantic proximity Read ↗

Stem-cell discovery platforms yield first clinical candidatesSemantic proximity Read ↗

Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapiesSemantic proximity Read ↗

From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial.Semantic proximity Read ↗

Harmonizing standards for producing clinical-grade therapies from pluripotent stem cellsSemantic proximity Read ↗

Defining Biomarkers in Stem Cell‐Derived Tissue Constructs for Drug and Disease ScreeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.